FDA pulls preterm-birth drug Makena and its generics from market after 12 years
April 06, 2023 at 13:57 PM EDT
The drug, which was approved using an accelerated pathway in 2011, showed no clinical benefit in a later trial.
Photography by Christophe Tomatis